ReviewCancer biology & therapy2023

Targeting CDK9 with selective inhibitors or degraders in tumor therapy: an overview of recent developments.

Lanshu Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.